BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36267769)

  • 1. High
    Yuan L; Hu C; Yu P; Bao Z; Xia Y; Zhang B; Wang Y
    Ann Transl Med; 2022 Sep; 10(18):990. PubMed ID: 36267769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cohort study using IL-6/Stat3 activity and PD-1/PD-L1 expression to predict five-year survival for patients after gastric cancer resection.
    Li XN; Peng YH; Yue W; Tao L; Zhang WJ
    PLoS One; 2022; 17(12):e0277908. PubMed ID: 36454780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 5. CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer.
    Wang C; Wang Y; Chen J; Wang Y; Pang C; Liang C; Yuan L; Ma Y
    BMC Gastroenterol; 2023 Aug; 23(1):283. PubMed ID: 37582713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the prognostic value and immune infiltration of
    Yang C; Song D; Zhao F; Wu J; Zhang B; Ren H; Sun Q; Qin S
    Front Oncol; 2022; 12():936952. PubMed ID: 36147913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
    Wang D; Wang QH; Luo T; Jia W; Wang J
    World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer.
    Yuan L; Xu J; Shi Y; Jin Z; Bao Z; Yu P; Wang Y; Xia Y; Qin J; Zhang B; Yao Q
    Front Oncol; 2022; 12():913670. PubMed ID: 35719985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
    Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
    PeerJ; 2023; 11():e14645. PubMed ID: 36919165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.
    Chen F; Yin S; Niu L; Luo J; Wang B; Xu Z; Yang G
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
    Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
    Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
    Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
    Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
    Ito S; Masuda T; Noda M; Hu Q; Shimizu D; Kuroda Y; Eguchi H; Tobo T; Utsunomiya T; Mimori K
    Oncology; 2020; 98(7):501-511. PubMed ID: 32380498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated CD4 T cells/Tregs derived immune-metabolism signature provide precise prognosis assessment for gastric cancer and beneficial for treatment option.
    Huo J; Shang Z; Fan X; Sun P
    Heliyon; 2024 Feb; 10(3):e25463. PubMed ID: 38327406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of LOX Suggests Poor Prognosis in Gastric Cancer.
    Zhu J; Luo C; Zhao J; Zhu X; Lin K; Bu F; Yu Z; Zou F; Zhu Z
    Front Med (Lausanne); 2021; 8():718986. PubMed ID: 34595188
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis.
    Lu B; Shi J; Cheng T; Wang C; Xu M; Sun P; Zhang X; Yang L; Li P; Wu H; Kuai X
    Front Pharmacol; 2024; 15():1397656. PubMed ID: 38887558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
    Ran T; Chen Z; Zhao L; Ran W; Fan J; Hong S; Yang Z
    Technol Cancer Res Treat; 2021; 20():15330338211004944. PubMed ID: 33784890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and Prognostic Value of Tumor-Infiltrating Lymphocytes and PD-L1 in Hepatocellular Carcinoma.
    Nie H; He T; Wang L; Zhang L
    Onco Targets Ther; 2021; 14():1377-1385. PubMed ID: 33658801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Fang F; Zhang T; Lei H; Shen X
    PeerJ; 2023; 11():e15613. PubMed ID: 37404478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
    Zhou F; Lin Q; Zheng Z
    Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.